QurCan Therapeutics

Profile

QurCan Therapeutics is advancing the next wave of genetic medicines for CNS diseases with TERP (Target-Engineered Responsive Polymer) technology, a non-viral delivery platform enabling safe, repeat intravenous delivery of RNA and biologics to the brain.

Website

qurcan.com

Contact


Event details

Date: November 9 - 11, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

<?php global $lang_id; switch ($lang_id) { case "fr": echo 'Total de 24'; break; case "pt-br": echo 'Total de 24'; break; case "es": echo 'Total de 24'; break; case "ja": echo '24 合計'; break; case "ko": echo '24 총계'; break; case "en": default: echo '24 in total'; break; } ?>